Patents Examined by Jane C. Oswecki
  • Patent number: 8951549
    Abstract: The invention relates to a method for reducing the concentration of amines and salts thereof, wherein the amines have the general chemical formula I R1R2R3N and the salts have the formula II R1R2R3N—H, wherein the amines and salts thereof exist in aqueous solution or aqueous suspension and are brought into contact with clinoptilolitic or clinoptilolite-containing mixtures. The method itself is suitable for use in food preparation and in the manufacture of foods. The inventive idea of reducing the concentration of amines and salts thereof is also useful in the manufacture of medical products for absorbing and for removing amines from the intestinal tract or the skin area of humans and animals.
    Type: Grant
    Filed: November 16, 2009
    Date of Patent: February 10, 2015
    Assignee: Froximun AG
    Inventors: Günter Steimecke, Steffen Hoffmann, Thomas Görner
  • Patent number: 8946280
    Abstract: The present invention relates to novel strigolactam derivatives of formula (I) to processes and intermediates for preparing them, to plant growth regulator compositions comprising them and to methods of using them for controlling the growth of plants and/or promoting the germination of seeds.
    Type: Grant
    Filed: December 9, 2011
    Date of Patent: February 3, 2015
    Assignee: Syngenta Participations AG
    Inventors: Mathilde Denise Lachia, Alain De Mesmaeker, Hanno Christian Wolf, Pierre Joseph Marcel Jung
  • Patent number: 8945521
    Abstract: A composition comprising a physical sunscreen, one or more adjuvants, and a carrier oil is provided. The composition also includes at least one of a compound having multiple phenyl groups, a film former or dispersant, and a silicone surfactant. The composition may also include an organic sunscreen. The combination of these ingredients exhibits an unexpected synergistic effect, in that the photoactive properties of the composition (e.g., SPF, UV absorption) are significantly higher than would be predicted based on the values for each of the components individually.
    Type: Grant
    Filed: April 20, 2012
    Date of Patent: February 3, 2015
    Assignee: Eveready Battery Company, Inc
    Inventors: Laura A. Spaulding, Patricia L. Scott, Alissa R. Frontauria
  • Patent number: 8945595
    Abstract: The disclosure provides compounds useful as insect repellents and compositions comprising such repellents. The disclosure further provides insect traps.
    Type: Grant
    Filed: March 4, 2009
    Date of Patent: February 3, 2015
    Assignee: The Regents of the University of California
    Inventors: Anandasankar Ray, Stephanie Lynn Turner
  • Patent number: 8940958
    Abstract: Method for the stabilization of contaminants within a material selected from soils, mining tailings and by-products, sludge wastes and industrial wastes, by mixing the material with an alum sludge composition. The composition includes one or more aluminum compound(s) and/or complex(es) together with a reactive carbon material.
    Type: Grant
    Filed: September 30, 2010
    Date of Patent: January 27, 2015
    Assignees: Commonwealth Scientific and Industrial Research Organisation, Ziltek Pty Ltd
    Inventor: Michael John McLaughlin
  • Patent number: 8940271
    Abstract: The invention includes compositions for transmucosal administration to an animal comprising at least one active agent and a pharmaceutically acceptable carrier. A preferred active agent is selected from the group consisting of meloxicam, carprofen, enrofloxacin, clemastine, diphenhydramine, digoxin, levothyroxine, cyclosporine, ondansetron, lysine, zolpidem, propofol, nitenpyram, ivermectin, milbemycin, and pharmaceutically acceptable salts, solvates and esters thereof. In another embodiment, the invention includes methods of treating or preventing a condition in an animal comprising transmucosally administering a composition comprising a therapeutically or prophylactically effective amount of an active agent and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: December 15, 2011
    Date of Patent: January 27, 2015
    Assignee: Abbott Laboratories
    Inventors: Mark C. Heit, Antonio M. Benitz, Dennis F. Steadman, David M. Petrick
  • Patent number: 8937083
    Abstract: This document discloses molecules having the following formula (“Formula One”): and processes related thereto.
    Type: Grant
    Filed: October 24, 2012
    Date of Patent: January 20, 2015
    Assignee: DowAgroSciences, LLC
    Inventors: Noormohamed M. Niyaz, Negar Garizi, Yu Zhang, Tony K. Trullinger, Ricky Hunter, Ann M. Buysse, Asako Kubota, Paul Renee LePlae, Jr., Daniel Knueppel, Christian T. Lowe, Dan Pernich, David A. Demeter, Timothy C. Johnson
  • Patent number: 8932644
    Abstract: The present disclosure is directed toward a composition and method of treating and preventing infection of pathogenic microorganisms and endopyhtic microorganisms in a plant through the use of phosphite compositions.
    Type: Grant
    Filed: July 1, 2014
    Date of Patent: January 13, 2015
    Inventor: Don M. Huber
  • Patent number: 8927477
    Abstract: A sanitary agent for treatment of a sanitary appliance includes a solid or semi-solid active body, designed to adhere to a wall of the sanitary appliance and including a treatment compound having at least an active element for treatment of the sanitary appliance. The body has an external surface thereof covered by a water-soluble film. In this way, the sanitary agent can be manipulated by hand for application thereof to a moist ceramic wall of a sanitary appliance to be treated, without the user's hands entering into contact with the components of the sanitary agent itself. Furthermore, any undesired loss of the components of the sanitary agent is avoided; these can be due to deformation of the sanitary agents before use thereof, displacements thereof and/or any dripping. A method for applying the sanitary agent for deterging, disinfecting and/or perfuming the sanitary appliance is also provided.
    Type: Grant
    Filed: May 27, 2011
    Date of Patent: January 6, 2015
    Assignee: RE.LE.VI. S.p.A.
    Inventor: Fabio Pagani
  • Patent number: 8927459
    Abstract: A method is provided for inhibiting plant growth by inducing hypothermia by applying a treating substance to summer annual weeds and grasses. Susceptible undesirable plants will be killed by this treatment, while non-susceptible desirable plants will not be adversely affected by this treatment. Compressed carbon dioxide may be applied to other summer grasses to cause the grasses to become dormant. An apparatus is provided for inducing hypothermia in undesirable plants by applying a treating substance. A canister capable of housing gas may be provided. A valve may be provided to control the amount and pressure of gas dispensed from the canister.
    Type: Grant
    Filed: March 8, 2013
    Date of Patent: January 6, 2015
    Assignee: Arctic, Inc.
    Inventors: Robby James Howerton, Gina Marie Stewart, Steven Lee Worm
  • Patent number: 8920715
    Abstract: An antimicrobial solution for disinfecting instruments in an automatic sterilization device, the solution comprising: a peracid reaction product formed in situ from combining a liquid acetyl donor with a solid source of peroxide, wherein the in situ reaction takes place in the sterilization device, along with a containment and delivery ampule for use in an automatic sterilization device, and methods for disinfecting a medical instrument employing the inventive antibacterial solution.
    Type: Grant
    Filed: August 7, 2006
    Date of Patent: December 30, 2014
    Assignee: Hemostasis, LLC
    Inventors: Keith Allen Roberts, Carl William Hahn, Gabriel P. Kern, Ryan A. Hoitink, Robert Orvin Crowder, John Henry Burban
  • Patent number: 8920830
    Abstract: The present invention relates to wound dressings having a wound contacting layer that contains a wound healing composition and which is adapted to maintain a temperature different from ambient, for example achieve and maintain a heat-absorbing effect on the underlying tissues. The specific physico-chemical structure of the devices of the invention allows fluid containment and absorption of wound secretions while avoiding skin macerations.
    Type: Grant
    Filed: July 7, 2009
    Date of Patent: December 30, 2014
    Assignee: Laboratoire Medidom S.A.
    Inventor: Burkhard Mathies
  • Patent number: 8916183
    Abstract: This document discloses molecules having the following formulas (“Formula One” &“Formula Two” and “Formula Three”) The Ar1, Het, Ar2, R1, R2, R3, R4, and R5 are further described herein.
    Type: Grant
    Filed: January 22, 2013
    Date of Patent: December 23, 2014
    Assignee: Dow AgroSciences, LLC.
    Inventors: Lindsey G. Fischer, Gary D. Crouse, Thomas C. Sparks, Erich W. Baum
  • Patent number: 8916181
    Abstract: An aerosol glitter composition for achieving the “sugar” glitter effect comprises a solvent, binder, square polyester glitter, optionally a rheology modifier, and propellant.
    Type: Grant
    Filed: October 6, 2011
    Date of Patent: December 23, 2014
    Assignee: The Sherwin-Williams Company
    Inventor: Christina M. Leposa
  • Patent number: 8912124
    Abstract: The invention relates to derivatives of (1-cyanocyclopropyl)phenylphosphinic acid of the formula (I) and to salts thereof, of the formula (II), for enhancing stress tolerance in plants to abiotic stress, preferably to drought stress, especially for enhancing plant growth and/or for increasing plant yield.
    Type: Grant
    Filed: April 6, 2011
    Date of Patent: December 16, 2014
    Assignee: Bayer Cropscience AG
    Inventors: Lothar Willms, Hans-Joachim Zeiβ, Marco Busch, Christopher Hugh Rosinger, Ines Heinemann, Isolde Häuser-Hahn, Martin Jeffrey Hills, Pascal Von Koskull-Döring
  • Patent number: 8906416
    Abstract: The invention relates to compound of generic formula (I) in which: R1 and R2 represent: OH, a hydrogen atom, a C1-C6 alkyl radical a C1-C6 alkoxy radical, a halogen, or OCOR3; R3 represents: a C1-C24 alkyl radical a C12-C24 alkenyl radical comprising at least one unsaturation; R4 represents: COR5, a glucide substituted or not by one or more acetyl radical(s); R5 represents: a C10-C24 alkyl radical or a C12-C24 alkenyl radical comprising at least one unsaturation; R6 and R7 represent:—simultaneously a hydrogen atom or a methyl radical, or—when R6 represents a hydrogen atom, R7 represents a C1-C6 alkyl radical or a phenyl substituted or not by one or more C1-C3 alkoxy radical(s) or one or more halogen(s) or—R6 and R7 are bonded together and form a C3-C6 cycloalkyl, and pharmaceutically or cosmetically acceptable salts.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: December 9, 2014
    Assignee: Pierre Fabre Dermo-Cosmetique
    Inventors: Stéphane Poigny, Françoise Belaubre
  • Patent number: 8901153
    Abstract: This document discloses molecules having the following formula (“Formula One”): and processes related thereto.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: December 2, 2014
    Assignee: Dow AgroSciences, LLC.
    Inventors: Ann M. Buysse, Noormohamed M. Niyaz, David A. Demeter, Yu Zhang, Martin J. Walsh, Asako Kubota, Ricky Hunter, Tony K. Trullinger, Christian T. Lowe, Daniel Knueppel, Akshay Patny, Negar Garizi, Paul Renee LePlae, Jr., Frank Wessels, Ronald Ross, Jr., Carl DeAmicis, Peter Borromeo
  • Patent number: 8900632
    Abstract: Coated dosage forms comprising a tablet core, preferably in compressed form, that has a coating over its exterior surface and one or more patterns debossed in the tablet surface are disclosed. Methods for manufacturing such dosage forms are also disclosed.
    Type: Grant
    Filed: February 1, 2013
    Date of Patent: December 2, 2014
    Assignee: McNeil-PPC, Inc.
    Inventors: Joel H. Waldman, Anthony S. Bean, Fernanda Franzoi
  • Patent number: 8895738
    Abstract: Disclosed are compounds of Formula 1, wherein R1 is phenyl or pyridinyl, each optionally substituted with Q and up to 3 substituents independently selected from R2; each R2 is independently halogen, cyano, SF5, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio or C1-C4 haloalkylthio; and Q is phenyl or pyridinyl, each optionally substituted with up to 5 substituents independently selected from the group consisting of halogen, cyano, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy and C1-C4 haloalkoxy. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound or a composition of the invention.
    Type: Grant
    Filed: December 22, 2011
    Date of Patent: November 25, 2014
    Assignee: E I du Pont de Nemours and Company
    Inventor: Thomas Francis Pahutski, Jr.
  • Patent number: 8887715
    Abstract: The invention relates to a method of delivering an agent to the pulmonary system of a compromised patient, in a single breath-activated step, comprising administering a particle mass comprising an agent from an inhaler containing less than 5 milligrams of the mass, wherein at least about 50% of the mass in the receptacle is delivered to the pulmonary system of a patient. The invention also relates to receptacles containing the particle mass and the inhaler for use therein.
    Type: Grant
    Filed: May 2, 2013
    Date of Patent: November 18, 2014
    Assignee: Civitas Therapeutics, Inc.
    Inventor: Jeffrey S. Hrkach